Summary
A rapid chromatographic procedure for the quantitative determination of the anthracycline antibiotics adriamycin and daunorubicin and their chief metabolites adriamycinol and daunorubicinol in plasma and urine is described. The extraction is performed using SEP-PAK silica cartridges. After filtration the eluate is chromatographed on a reversed-phase column.
Similar content being viewed by others
References
Aszalos A (1984) Analysis of antitumor antibiotics by high pressure liquid chromatography (HPLC). J Liq Chromatogr 7 (S-1): 69
Carter SK (1975) Adriamycin—a review. J Natl Cancer Inst 55: 1265
Davis HL, Davis TE (1979) Daunorubicin and adriamycin in cancer treatment: an analysis of their roles and limitations. Cancer Treat Rep 63: 89
Eksborg S, Ehrsson H, Andersson I, Beran M (1978) Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma of leukemic patients. J Chromatogr 153: 211
Erttmann R, Grandt U, Erb N, Landbeck G (1986) Zur Pharmakokinetik von Doxorubicin. Ergeb Paed Onkol 10 (in press)
Hulhoven R, Desager JP (1976) Quantitative determination of low levels of daunomycin and daunomycinol in plasma by high-performance liquid chromatography. J Chromatogr 125: 369
Pierce RN, Jatlow PI (1979) Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection. J Chromatogr 164: 471
Robert J (1980) Extraction of anthracyclines from biological fluids for HPLC evaluation. J Liq Chromatogr 3: 1561
Author information
Authors and Affiliations
Additional information
The authors wish to thank the Werner Otto Stiftung, Hamburg, and the Hamburger Landesverband für Krebsbekämpfung und Krebsforschung e. V. for their generous financial support
Rights and permissions
About this article
Cite this article
Erb, N., Erttmann, R. & Landbeck, G. A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol. Cancer Chemother. Pharmacol. 17, 53–55 (1986). https://doi.org/10.1007/BF00299866
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00299866